| 1BIS | B:56-209; A:56-209 | HIV-1 INTEGRASE CORE DOMAIN |
| 1BIU | A:56-209; B:56-209; C:56-209 | HIV-1 INTEGRASE CORE DOMAIN COMPLEXED WITH MG++ |
| 1BIZ | A:54-208; B:58-212 | HIV-1 INTEGRASE CORE DOMAIN |
| 1DTQ | A:427-537 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-1 (PETT131A94) |
| 1DTT | A:427-541 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2 (PETT130A94) |
| 1EX4 | A:56-210; B:56-210 | HIV-1 INTEGRASE CATALYTIC CORE AND C-TERMINAL DOMAIN |
| 1EXQ | A:56-209; B:56-209 | CRYSTAL STRUCTURE OF THE HIV-1 INTEGRASE CATALYTIC CORE DOMAIN |
| 1HNV | A:427-557 | STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS |
| 1HPZ | A:427-556 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 1HQE | A:427-554 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 1HQU | A:427-556 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 1HYV | A:57-210 | HIV INTEGRASE CORE DOMAIN COMPLEXED WITH TETRAPHENYL ARSONIUM |
| 1HYZ | A:57-210 | HIV INTEGRASE CORE DOMAIN COMPLEXED WITH A DERIVATIVE OF TETRAPHENYL ARSONIUM. |
| 1K6Y | B:56-212; A:56-210; C:56-209; D:56-211 | CRYSTAL STRUCTURE OF A TWO-DOMAIN FRAGMENT OF HIV-1 INTEGRASE |
| 1QS4 | B:56-209; C:56-209; A:56-209 | CORE DOMAIN OF HIV-1 INTEGRASE COMPLEXED WITH MG++ AND 1-(5-CHLOROINDOL-3-YL)-3-HYDROXY-3-(2H-TETRAZOL-5-YL)-PROPENONE |
| 2WOM | A:427-558 | CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (K103N). |
| 2WON | A:427-552 | CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (WILD-TYPE). |
)
)